Welcome to LookChem.com Sign In|Join Free

CAS

  • or

562-10-7

Post Buying Request

562-10-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

562-10-7 Usage

Uses

Different sources of media describe the Uses of 562-10-7 differently. You can refer to the following data:
1. H1 Histamine receptor antagonist. Antihistaminic; sedative; hypnotic.
2. antihistaminic, hypnotic
3. Doxylamine succinate salt has been used as a therapeutic drug to check developmental toxicity.

General Description

Different sources of media describe the General Description of 562-10-7 differently. You can refer to the following data:
1. The acid succinate salt (bisuccinate)of doxylamine, 2-[ -[2-(dimethylamino)ethoxy]- -methylbenzyl]pyridine bisuccinate (Decapryn Succinate), isa white to creamy-white powder with a characteristic odor.It is soluble in water (1:1), alcohol (1:2), and chloroform(1:2). A 1% solution has a pH of about 5.Doxylamine succinate is comparable in potency todiphenhydramine. It is indicated for the relief of seasonalrhinitis symptoms, but is also used as a nighttime sedative.Concurrent use of alcohol and other CNS depressantsshould be avoided.
2. White or creamy white powder. pH (1% aqueous solution) between 4.9 and 5.1.

Air & Water Reactions

Water soluble.

Health Hazard

SYMPTOMS: Symptoms of exposure to Doxylamine succinate may include drowsiness, excitability, nervousness, dizziness and sleeplessness.

Fire Hazard

Flash point data for Doxylamine succinate are not available. Doxylamine succinate is probably combustible.

Biochem/physiol Actions

H1 histamine receptor antagonist; hypnotic.Doxylamine suppresses histamine at the H1 receptor. It is associated with the short term management of insomnia and temporary relief of common cold symptoms. On the other hand, doxylamine intoxication is linked with rhabdomyolysis and secondary acute renal failure.Studies in mice show that doxylamine induces liver microsomal cytochrome P450 and other enzymes involved in thyroxine (T4) metabolism. In combination with pyridoxine hydrochloride, this drug is used to treat morning sickness.

Check Digit Verification of cas no

The CAS Registry Mumber 562-10-7 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 5,6 and 2 respectively; the second part has 2 digits, 1 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 562-10:
(5*5)+(4*6)+(3*2)+(2*1)+(1*0)=57
57 % 10 = 7
So 562-10-7 is a valid CAS Registry Number.
InChI:InChI=1/C17H22N2O.C4H6O4/c1-17(20-14-13-19(2)3,15-9-5-4-6-10-15)16-11-7-8-12-18-16;5-3(6)1-2-4(7)8/h4-12H,13-14H2,1-3H3;1-2H2,(H,5,6)(H,7,8)/p-2

562-10-7 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Sigma-Aldrich

  • (PHR1420)  Doxylamine Succinate  pharmaceutical secondary standard; traceable to USP, PhEur

  • 562-10-7

  • PHR1420-1G

  • 1,149.88CNY

  • Detail
  • Sigma-Aldrich

  • (Y0001492)  Doxylamine for system suitability  European Pharmacopoeia (EP) Reference Standard

  • 562-10-7

  • Y0001492

  • 1,880.19CNY

  • Detail
  • Sigma-Aldrich

  • (Y0001562)  Doxylamine hydrogen succinate  European Pharmacopoeia (EP) Reference Standard

  • 562-10-7

  • Y0001562

  • 1,880.19CNY

  • Detail
  • Sigma

  • (D3775)  Doxylamine succinate salt  

  • 562-10-7

  • D3775-5G

  • 795.60CNY

  • Detail
  • Sigma

  • (D3775)  Doxylamine succinate salt  

  • 562-10-7

  • D3775-50G

  • 4,481.10CNY

  • Detail
  • Cerilliant

  • (D-045)  Doxylamine succinate solution  1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material

  • 562-10-7

  • D-045-1ML

  • 497.25CNY

  • Detail

562-10-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 16, 2017

Revision Date: Aug 16, 2017

1.Identification

1.1 GHS Product identifier

Product name Doxylamine succinate salt

1.2 Other means of identification

Product number -
Other names butanedioic acid,N,N-dimethyl-2-(1-phenyl-1-pyridin-2-ylethoxy)ethanamine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:562-10-7 SDS

562-10-7Relevant articles and documents

Synthesis method of doxylamine succinate

-

Paragraph 0056; 0058; 0059; 0061; 0062; 0064-0068, (2019/12/09)

The invention discloses a synthesis method of doxylamine succinate. The method includes: (1) adding 2-pyridylphenylmethylcarbinol into an organic solvent I, adding a catalyst, strong base or alkali metal and 2-dimethylaminochloroethane respectively, performing heating to 100-110DEG C and carrying out reaction for 1-2h; then conducting cooling and filtering; subjecting an aqueous phase to backwashing with the organic solvent I, then performing heating to 70-80DEG C, adding activated carbon for decolorization, then performing filtering, then adding a low-boiling-point organic solvent for extraction, drying the extracted organic phase, and finally conducting reduced pressure concentration at 50-60DEG C to dryness to obtain doxylamine; and (2) dissolving the doxylamine in an organic solvent II, adding succinic acid at 50-60DEG C for reaction, then employing medicinal activated carbon for decolorization and filtering, conducting cooling to a temperature at or below 5DEG C, carrying out stirring crystallization, then performing pumping filtering, and conducting washing with the precooled organic solvent II, and finally performing vacuum drying to obtain the doxylamine succinate. The synthesis method provided by the invention simplifies operation, lowers energy consumption, and has high reaction conversion rate and high yield.

Preparation method of doxylamine succinate

-

Paragraph 0048-0050, (2017/01/19)

The invention discloses a preparation method of doxylamine succinate. The preparation method comprises following steps: step 1, 2-pyridyl phenyl methyl carbinol is dissolved in an organic solvent, and is reacted with 2-dimethylaminoethyl chloride hydrochloride at high temperature, after reaction, target product N,N-dimethyl-2-[1-phenyl-1-(2-pyridine)oxethyl]ethylamine is obtained via quenching extracting separation; and step 2, N,N-dimethyl-2-[1-phenyl-1-(2-pyridine) oxethyl]ethylamine obtained in the step 1 and succinic acid are subjected to salt forming in an organic solvent; and finished product N,N-dimethyl-2-(1-phenyl-1-(2-pyridine)ethoxy)ethanamine succinate (doxylamine succinate) is obtained via cooling crystallization. The preparation method is simple, safe, and reliable, is high in doxylamine succinate yield, and is suitable for industrialized enlarged production; and post-treatment is simple and convenient.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 562-10-7